Poland - Miscellaneous medicinal products
For more information and to make a bid you will need to go to the third party website.
Details
Provided by- Opportunity closing date
- 24 February 2020
- Opportunity publication date
- 22 January 2020
- Category
- 33690000: Various medicinal products
- Value of contract
- to be confirmed
- Your guide to exporting
Description
"Supply of oncological medicinal products (Bleomycin, Cisplatin, Cladribine, Cytarabine, Dacarbazine, Doxorubicin, Epirubicin ...)For COZL "Part No 1 - Bleomycin - 15mg. Inj liof.., pcs 1 000 "Supply of oncological medicinal products (Bleomycin, Cisplatin, Cladribine, Cytarabine, Dacarbazine, Doxorubicin, Epirubicin ....) For the purposes of the COZL "Part No 2 - Cisplatin -100mg concentrate, physico-chemical stability after opening a minimum of 24hrs CHPL entries, g 300 "Supply of oncological medicinal products (Bleomycin, Cisplatin, Cladribine, Citarabine, Dacarbazine, Doxorubicin, Epirubicin ....)For COZL "Part No 3 - Cladribine - 0,01g/10ml.inj, g 0,7 "Supply of oncological medicinal products (Bleomycin, Cisplatin, Cladribine, Cytarabine, Dacarbazine, Doxorubicin, Epirubicin ....) For the purposes of the COZL's 'Part No 4 - Citarabine - 0,1 g; 0,5 g; 1 g; 2 g; Solution for injection, physico-chemical stability after opening 24h; g 600 'Supply of oncological medicinal products (Bleomycin, Cisplatin, Cladribine, Citarabine, Dacarbazine, Doxorubicin, Epirubicin ....)For COZL "Part No 5 - Dacarbazine - 0,1g; 0,2g; 0,5g; 1g; g 360 "Supply of oncological medicinal products (Bleomycin, Cisplatin, Cladribine, Citarabine, Dacarbazine, Doxorubicin, Epirubicin ....)For the purposes of the COZL "Part No 6 - Doxorubicin - Concentrate for solution for infusion 10mg, 50mg, 100mg, 200mg, pot life after opening min 24h entry in the CHPL; g 240 "Supply of oncological medicinal products (Bleomycin, Cisplatin, Cladribine, Citarabine, Dacarbazine, Doxorubicin, Epirubicin ....) For the purposes of the COZL "Part No 7 - Epirubicin - 0,01g; 0,05g; 0,1 inj shelf life of the finished solution min 48h CHPL entries; g 20 "Supply of oncological medicinal products (Bleomycin, Cisplatin, Cladribine, Cytarabine, Dacarbazine, Doxorubicin, Epirubicin ....)For the purposes of COZL "Part No. 8 - Epoetin Beta - 30 000jm/0,6ml amp-sharp injection solution.;pcs 300 "Supply of oncological medicinal products (Bleomycin, Cisplatin, Cladribine, Cytarabine, Dacarbazine, Doxorubicin, Epirubicin ....) For the purposes of the COZL's 'Part No 9 - Erlotinib - 0,025g; 0,1g; 0,15g/tablet coated; g 234 'Supply of oncological medicinal products (Bleomycin, Cisplatin, Cladribine, Cytarabine, Dacarbazine, Doxorubicin, Epirubicin ....) For the purposes of the COZL "Part No 10 - Ethoposide - Concentrate 100mg,200mg,400mg/inj vial after opening min 24h entry in the CHPL; g 320 "Supply of oncological medicinal products (Bleomycin, Cisplatin, Cladribine, Cytarabine, Dacarbazine, Doxorubicin, Epirubicin ....)For COZL "Part No 11 - Ifosfamide - 1g, 2g powder; g 2 300 "Supply of oncological medicinal products (Bleomycin, Cisplatin, Cladribine, Cytarabine, Dacarbazine, Doxorubicin, Epirubicin ....)For COZL "Part No. 12 - Mitotane - 500mg/tablet; pcs 22 000 "Supply of oncological medicinal products (Bleomycin, Cisplatin, Cladribine, Cytarabine, Dacarbazine, Doxorubicin, Epirubicin ...)For COZL "Part No. 13 - Paclitaxel - 0,03g; 0,1g; 0,3g vial. Shelf life after dissolution min.48h enrolment in the CHPL; g 900 'Supply of oncological medicinal products (Bleomycin, Cisplatin, Cladribine, Cytarabine, Dacarbazine, Doxorubicin, Epirubicin ....) For COZL "Part No 14 - Sunitinib - 0,0125g; 0,025g; 0,05g capsule; g 850 "Supply of oncological medicinal products (Bleomycin, Cisplatin, Cladribine, Cytarabine, Dacarbazine, Doxorubicin, Epirubicin ....)For COZL "Part No 15 - Temozolomide - 0,005g; 0,02g; 0,1g; g 600 "Supply of oncological medicinal products (Bleomycin, Cisplatin, Cladribine, Cytarabine, Dacarbazine, Doxorubicin, Epirubicin ...)For COZL "Part No 16 - Topotecan cap. - 0,001g; 0,00025g capsule; g 0,5 "Supply of oncological medicinal products (Bleomycin, Cisplatin, Cladribine, Cytarabine, Dacarbazine, Doxorubicin, Epirubicin ...)For the purposes of the COZL "Part No 17 - Topotecan inj. - 0,001g; 0,004g concentrate for infusion, vial shelf life after opening at least 24 hours CHPL registration; g 0,4 "Supply of oncological medicinal products (Bleomycin, Cisplatin, Cladribine, Cytarabine, Dacarbazine, Doxorubicin, Epirubicin ....)For COZL "Part No 18 - Trabectydine - 0,001g; 0,00025g inj; g 0,1 "Supply of oncological medicinal products (Bleomycin, Cisplatin, Cladribine, Citarabine, Dacarbazine, Doxorubicin, Epirubicin ....) For COZL "Part No 19 - Vinblastin - 0,005g inj powder + solvent; g 3 "Supply of oncological medicinal products (Bleomycin, Cisplatin, Cladribine, Citarabine, Dacarbazine, Doxorubicin, Epirubicin ....) For the purposes of the COZL's 'Part No 20 - Vincristini sulfas - 0,001g/1ml inj a 1ml and 5ml solution for injection; g 1,6 'Supply of oncological medicinal products (Bleomycin, Cisplatin, Cladribine, Cytarabine, Dacarbazine, Doxorubicin, Epirubicin ....) For COZL's' Part No 21 - Rituximab - 0,1 g; 0,5 g Concentrate for solution for infusion, g 800 'Supply of oncological medicinal products (Bleomycin, Cisplatin, Cladribine, Citarabine, Dacarbazine, Doxorubicin, Epirubicin ....) For COZL "Part No 22 - Rituximab solution - Solution for injection 1400mg; pcs 260 "Supply of oncological medicinal products (Bleomycin, Cisplatin, Cladribine, Cytarabine, Dacarbazine, Doxorubicin, Epirubicin ....)For COZL "Part No 23 - Crizotinibum - 250mg cap; pcs 900200mg cap.Item 120 "Supply of oncological medicinal products (Bleomycin, Cisplatin, Cladribine, Cytarabine, Dacarbazine, Doxorubicin, Epirubicin ....) For the purposes of the COZL's 'Part No 24 - Irinotecan - 40mg, 100mg, 300mg concentrate for solution for infusion, durability after dissolution in the bag min 48h confirmed in the CHPD; g 800 'Supply of oncological medicinal products (Bleomycin, Cisplatin, Cladribine, Cytarabine, Dacarbazine, Doxorubicin, Epirubicin ....)For COZL "Part No. 25 - Docetaxel - 20mg, 80mg, 160mg and/or 140mg, durability after dissolution in the bag min. 24h confirmed by the CHPL; g 220 'Supply of oncological medicinal products (Bleomycin, Cisplatin, Cladribine, Cytarabine, Dacarbazine, Doxorubicin, Epirubicin ....) For COZL "Part No 26 - Fulvestrant - Solution for injection 250mg/5ml a 2amp; op 1 800 "Supply of oncological medicinal products (Bleomycin, Cisplatin, Cladribine, Citarabine, Dacarbazine, Doxorubicin, Epirubicin ....)For COZL "Part No. 27 - Obinutuzumab - Concentrate for the preparation of a solution for infusion 1000mg vial a 40ml; pcs. 130 "Supply of oncological medicinal products (Bleomycin, Cisplatin, Cladribine, Cytarabine, Dacarbazine, Doxorubicin, Epirubicin ....) For COZL "Part No 28 - Trastuzumab - Inj 1400mg/11,7ml; pcs 3 800 "Supply of oncological medicinal products (Bleomycin, Cisplatin, Cladribine, Cytarabine, Dacarbazine, Doxorubicin, Epirubicin ....) For the purposes of the COZL's 'Part No 29 - Liposomal Doxorubicin - Powder + solvent 50 mg nonpegylated; g 28 'Supply of oncological medicinal products (Bleomycin, Cisplatin, Cladribine, Citarabine, Dacarbazine, Doxorubicin, Epirubicin ....)For COZL "Part No 30 - Lipegfilgrastim- amp - stirrup 0,6ml/6mg; pcs 1 800 "Supply of oncological medicinal products (Bleomycin, Cisplatin, Cladribine, Cytarabine, Dacarbazine, Doxorubicin, Epirubicin ....)For COZL "Part No. 31 - Imatinib- cap. tablets 400mg and 30pcs; op 200Kaps. tablets 100mg and 60pcs; op 10 "Supply of oncological medicinal products (Bleomycin, Cisplatin, Cladribine, Cytarabine, Dacarbazine, Doxorubicin, Epirubicin ....) For the purposes of the COZL's 'Part No 32 - Temsirolimusum- Concentrate for the preparation of a solution for infusion of 30 mg; pcs (1+1) 200 'Supply of oncological medicinal products (Bleomycin, Cisplatin, Cladribine, Citarabine, Dacarbazine, Doxorubicin, Epirubicin ....)For COZL "Part No 33 - Olaparyb- op a 448pcs; op 120 "Supply of oncological medicinal products (Bleomycin, Cisplatin, Cladribine, Citarabine, Dacarbazine, Doxorubicin, Epirubicin ....)For COZL "Part No 34 - Acidum zoledrenicum - Concentrate for the preparation of a solution for infusion 4mg/5ml a 1 vial; pcs 650 "Supply of oncological medicinal products (Bleomycin, Cisplatin, Cladribine, Cytarabine, Dacarbazine, Doxorubicin, Epirubicin ....)For COZL "Part No 35 - Bortezomib - vial 3,5 mg; 1 mg powder for solution for injection; g 3 "Supply of oncological medicinal products (Bleomycin, Cisplatin, Cladribine, Cytarabine, Dacarbazine, Doxorubicin, Epirubicin ....)For COZL "Part No 36 - Pembrolizumab - Powder for concentrate, solution for infusion 50 mg; pcs 20 Powder for concentrate, solution for infusion 100 mg; pcs 850 "Supply of oncological medicinal products (Bleomycin, Cisplatin, Cladribine, Citarabine, Dacarbazine, Doxorubicin, Epirubicin ....)For COZL "Part No 37 - Trametinib - 2 mg tabl a 30; op 3300,5 mg tabl a 30; op 10 "Supply of oncological medicinal products (Bleomycin, Cisplatin, Cladribine, Citarabine, Dacarbazine, Doxorubicin, Epirubicin ....) For COZL "Part No 38 - Liposomal Doxorubicin - Concentrate for the preparation of solution for infusion 2mg/ml; pcs 400 "Supply of oncological medicinal products (Bleomycin, Cisplatin, Cladribine, Citarabine, Dacarbazine, Doxorubicin, Epirubicin ...)For COZL "Part No 39 - Capecytabine - Tabl powl 150mg; pcs 36 000Tabl. 500mg; pcs 240 000 "Supply of oncological medicinal products (Bleomycin, Cisplatin, Cladribine, Cytarabine, Dacarbazine, Doxorubicin, Epirubicin ....) For the purposes of the COZL's 'Part No 40 - Trastuzumab - Powder for concentrate for solution for infusion a 150mg and 420mg; g 700 'Supply of oncological medicinal products (Bleomycin, Cisplatin, Cladribine, Citarabine, Dacarbazine, Doxorubicin, Epirubicin ....)For the needs of COZL "Part No. 41 - Dazatinib -Table covers 100mg and 30pcs op 30Table covers 140mg and 30pcs op 4Table covers 20mg and 60pcs op 4Table covers 50mg and 60pcs op 4Table covers.a 80mg a 30pcs op 8 "Supply of oncological medicinal products (Bleomycin, Cisplatin, Cladribine, Cytarabine, Dacarbazine, Doxorubicin, Epirubicin ....)For the purposes of the COZL "Part No 42 - Pomalidomidum - cps. a 1, 2, 3, 4mg and 21pcs; op 180 "Supply of oncological medicinal products (Bleomycin, Cisplatin, Cladribine, Citarabine, Dacarbazine, Doxorubicin, Epirubicin ....)For COZL "Part No 43 - Bicalutamide - 50mg of the table and 28pcs; op 1 800150mg of the table and 28pcs; op 10 "Supply of oncological medicinal products (Bleomycin, Cisplatin, Cladribine, Cytarabine, Dacarbazine, Doxorubicin, Epirubicin ....) For COZL "Part No. 44 - Bosutynib - Tabl a 100mg 28pcs; op 6Tabl a 500mg 28pcs; op 10 "Supply of oncological medicinal products (Bleomycin, Cisplatin, Cladribine, Cytarabine, Dacarbazine, Doxorubicin, Epirubicin ....)For COZL "Part No. 45 - Filgrastin - 48 ml. J.m amp - arrow a 0.5ml; pcs 4 00030 ml. J.m amp - arrow a 0.5ml; pcs. 1 400 "Supply of oncological medicinal products (Bleomycin, Cisplatin, Cladribine, Cytarabine, Dacarbazine, Doxorubicin, Epirubicin ....) For the purposes of the COZL's 'Part No 46 - Gemcytabine - 0,2 g; 1 g; 2 g Concentrate for solution for infusion, the shelf life of the vial after opening a minimum of 24 hours' CHPL entry; g 2 100 'Supply of oncological medicinal products (Bleomycin, Cisplatin, Cladribine, Cytarabine, Dacarbazine, Doxorubicin, Epirubicin ....)For COZL "Part No 47 - Nilotinib - 0,2 g a 112 cps; op 20 "Supply of oncological medicinal products (Bleomycin, Cisplatin, Cladribine, Cytarabine, Dacarbazine, Doxorubicin, Epirubicin ....) For COZL's 'Part No 48 - Paclitaxelum albuminatum - Suspension powder for infusion, vial a 100mg; op 350 'Supply of oncological medicinal products (Bleomycin, Cisplatin, Cladribine, Citarabine, Dacarbazine, Doxorubicin, Epirubicin ....)For the purposes of the COZL "Part No 49 - Bendamustin - Powder for concentrate solution for infusion 2,5mg/ml and 25mg and 100mg; g 70 "Supply of oncological medicinal products (Bleomycin, Cisplatin, Cladribine, Cytarabine, Dacarbazine, Doxorubicin, Epirubicin ....)For COZL "Part No 50 - Aflibercept -25mg/ml and 4ml; pcs 26025mg/ml and 8ml; pcs 20 "Supply of oncological medicinal products (Bleomycin, Cisplatin, Cladribine, Cytarabine, Dacarbazine, Doxorubicin, Epirubicin ....)For COZL "Part No. 51 - Pegfilgrastim -0.006g/0.6ml; op 800
- Opportunity closing date
- 24 February 2020
- Value of contract
- to be confirmed
About the buyer
- Address
- Centrum Onkologii Ziemi Lubelskiej im. św. Jana z Dukli ul. dr. K. Jaczewskiego 7 Lublin 20-090 Poland
- Contact
- zampub@cozl.eu
The deadline to apply for this opportunity has passed.
Visit the
opportunities page
to find another.